• Neuroscience & Pharmacology Discussion Welcome Guest
    Posting Rules Bluelight Rules
    Recent Journal Articles Chemistry Mega-Thread
    FREE Chemistry Databases! Self-Education Guide

  • N&PD Moderators: Skorpio

I Like to Draw Pictures of Random Molecules

Status
Not open for further replies.
Spiroxetamine

tssssty_zpszz5npj1m.png
 
Oh yeah, that's too bad - thought it would be nasty but at least survives... any way to make poly-GHB or something of the sort though? :D Oh yeah obviously, just a polyester - makes polybutyrate basically - a biodegradable plastic that does use 1,4-BDO in its synthesis... fun plastics - speaking of fun plastics and BDO:

Bindeez (also marketed as Aqua Dots,[1] Beados,[2] and Pixos[3]) are a children's toy. It was subject to a multi-national product recall after it was found that the Wangqi Product Factory in Shenzhen, China had used a cheap chemical that was a pharmacologically active sedative prodrug instead of the safer specified one in some shipped toys, resulting in the illness and hospitalization of some children who ingested the beads
Click to expand...

spiroxetamine is a cool name, and reminds me remotely of DXM with one of the rings unhinged... but no that ^ stuff is pretty shuffled compared to that. I wonder what lies in between though... will try to draw something later..
Would it still be called a spiro compound if the N-alkyl chain loops back to the cyclohexane ring instead of the phenyl ring? I guess you'd have to check out the 7 possible compounds you can make by attaching that alkyl chain to see what kind of constraining improves potency. Hooking it up to some of the right places might also prevent metabolism, although most dissociatives suffer from too long duration rather than too short.

Could a carbonyl be placed on one of the rings of DXM that would be the equivalent position of where K / MXE have it, and be expected to have decent effects on activity?
 
Last edited:
Solipsis said:
any way to make poly-GHB or something of the sort though? :D Oh yeah obviously, just a polyester - makes polybutyrate basically - a biodegradable plastic that does use 1,4-BDO in its synthesis...
Click to expand...

That's very easy:
- Just perform a ring-opening polymerization (ROP) using either (snip!), (snip!) or (snip!) (Me-heh:p) on GBL it will give poly(4-hydroxybutyrate) already. (4-PHB)
- For that 1,4-BD is is used for synthesis of PBS (Polybutylene Succinate)

Our stomach cannot effectively hydrolyze them; though
 
Solipsis said:
Could a carbonyl be placed on one of the rings of DXM that would be the equivalent position of where K / MXE have it, and be expected to have decent effects on activity?
Click to expand...
There are morphinans with a keto attached like ketocyclazocine
220px-Ketazocine_structure.svg.png



Most are Kappa selective agonists dysphoric the levo-rotatory group. But am not sure if ketocyclazocine congener of DXM ie with the "right" stereochemistry (ie dextro) are known...:
levarphanol ---> ketocylazocine (and similar morphinans)
dextromethorphan--->ketomethorphan? Oxo-methorphan?? :)
 
To answer my own question (I think) though: I didn't have an easy time trying to figure it out, but I think it's not possible because the 9-position of DXM which seems to correspond best with where some of the ACAs have their carbonyl, is a tertiary carbon because of the phenanthrene structure.

Thats interesting though! ^
 
2kuIxh.jpg


Further restrict rotation, wonder if efficacious as a stim.?

The rationale was this:

d5JERl.jpg


But it doesn't seem to do much in all cases unless there is a 4 position addition, or the di-chloro is added which is a bit of a cheat.
 
The thing with decreasing flexibility is that if a restricted molecule is able to bind in an active conformation, the activity increases, but if it can't, the activity will drop. That's why they tested different compounds in that research on methylphenidate analogues trying to put the carbonyl into different fixed spaces. By restricting molecule conformationally you basically make it less capable of unbinding via rotation around certain bonds, I guess.
 
DotChem said:
There are morphinans with a keto attached like ketocyclazocine
220px-Ketazocine_structure.svg.png



Most are Kappa selective agonists dysphoric the levo-rotatory group. But am not sure if ketocyclazocine congener of DXM ie with the "right" stereochemistry (ie dextro) are known...:
levarphanol ---> ketocylazocine (and similar morphinans)
dextromethorphan--->ketomethorphan? Oxo-methorphan?? :)
Click to expand...

10-ketodextromethorphan was tried in some research and it didn't turn out to be interesting for sure, if I remember well, it was even weaker than DXM itself as a NMDA antagonist or whatever. But anyway, the keto moiety decreases basicity of the amine, the same thing must be happening in ketamine as well, though its potency is likely decreased by o-chloro as well, yet the qualitative gain is more than potency drop. For toxicity it's probably bad though.
 
ZFfPgo.jpg


This is based on further rigidifying the quinolizidine MPH RRAs in a way that shouldn't hinder/hamper binding. I really like the look of it.

The two functionalities are facing in differing places because of the limit of bonds, when they should be R, I tweaked it a bit:

1AjB7p.jpg


Started with caffeine and butalbital, ended up with this:

f1u9gO.jpg


Well 'la-tee-dah' it's planar (aryl is, anyway) should work like m-amp:

0TLxly.jpg


What happens if you pull those labile oxygens off of the 3 & 6 positions of morphine? (I extended the six because I couldn't see that doing anything but lengthening half life) =

K2FoHr.jpg
 
Last edited:
xHTDRRh.png

^ Im guessing this one is inactive
V5BTMCC.png

^ inspired by ibuprofen
phm4lHN.png

^inspired by naproxen
qaKplO5.png

^ idk about his one
oLAb17y.png

^ inspired from the guy who was obsessed about damascone =D
c67S4mb.png

I couldn't even remember when I drew this one but it looks interesting.

btw im new to this place and I have been lurking this thread for a couple months and finally decided to share.
 
adder said:
10-ketodextromethorphan was tried in some research and it didn't turn out to be interesting for sure, if I remember well, it was even weaker than DXM itself as a NMDA antagonist or whatever. But anyway, the keto moiety decreases basicity of the amine, the same thing must be happening in ketamine as well, though its potency is likely decreased by o-chloro as well, yet the qualitative gain is more than potency drop. For toxicity it's probably bad though.
Click to expand...

I see..One would expect them to behave similarly to ketamine or MXE. But I think your're right: the alfa-keto group would decrease the pKa of the amine hugely(2 log units??. That's probably the reason why they suck? Note that in ketamine and PCP congener MXE, the pKa is still way higher than physiological pH (7.4). For ketamine it is about 8.5 which means much of molecule will be charged in the body anyway. So I guess in the case of K and MXE, it wont really affect binding. I am not sure what the pKa of the keto analog of DXM would be.??

NB:In the case of amphetamines and cathinones though, I always thought the drop of the pKa of the amine by the keto group has something to do with their pharmacological profile: ie from DRI (Amphetamine-like) ------> DRA (cocaine like cathinones). Cathinones pKa is much lower than that of the corresponping AMPH. At the very least, it would affect their pharmacokinetic like absorption and brain distribution.
 
I don't mean the effect of pKa with respect to the ratio of charged and uncharged form in the blood. The molecules clearly get to the brain in their freebase form as a charged amine can't pass the blood-brain barrier) and the amine gets protonated at the target site interacting with an aminoacid residue with a positively charged side-chain, so the drop in basicity here could mean lower affinity at the NMDA receptor site DXM/DXO interacts with, but if it's a meaningful drop I have no idea. I imagine the carbonyl group itself is electronically and/or sterically unfavoured there for the binding, I doubt such a small change in an otherwise lipophilic molecule could affect the amount that gets to the brain much. I tried overlaying DXM with ketamine and dizocilpine some time ago and if there is any position in DXM that might correlate with the carbonyl carbon of ketamine, it is not C10, but rather C14 which is a tertiary carbon atom (I'm using the morphinan numbering here, so it's the carbon atom that bears an extra hydroxy group in oxymorphone vs. hydromorphone). However, the site that DXO binds to may not be the same site that ketamine binds to, I remember reading an article on how DXO effects were blocked by some specific ligand that didn't block ketamine or some other arylcyclohexanamine effects (or the other way around, I'd have to find it again), the conclusion was that the site for DXO is a different one. If it is so, then comparing DXO structure with ketamine and planning structural changes based on SAR of arylcyclohexanamines makes little sense anyway.
 
I dunno, I wish that when someone posts a molecule which is not totally obvious, they'd write what they think about it or why they chose a certain structure.
 
Status
Not open for further replies.
Top